Jacobs Hannah M, Soslow Jonathan H, Cornicelli Matthew D, Merves Shae A, Garg Ruchira, Patel Mehul D, Agarwal Arpit, Misra Nilanjana, DiLorenzo Michael P, Campbell M Jay, Steele Jeremy, Co-Vu Jennifer, Robinson Joshua D, Lee Simon, Johnson Jason N
Division of Pediatric Cardiology, Nationwide Children's Hospital, Columbus, Ohio, USA.
Division of Pediatric Cardiology, Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee, USA.
J Cardiovasc Magn Reson. 2024;26(2):101091. doi: 10.1016/j.jocmr.2024.101091. Epub 2024 Sep 11.
Cardiovascular magnetic resonance (CMR) is used to diagnose myocarditis in adults and children based on the original Lake Louise criteria (LLC) and more recently the revised LLC. The major change included in the revised LLC was the incorporation of parametric mapping, which significantly increases the sensitivity and specificity of diagnosis. Subsequently, scientific statements have recommended the use of parametric mapping in the diagnosis of myocarditis in children. However, there are some challenges to parametric mapping that are unique to the pediatric population. Our goal is to characterize clinical CMR and parametric mapping practice patterns for the diagnosis of myocarditis in pediatric centers.
The Cardiovascular Magnetic Resonance Evaluation in Return to Athletes for Myocarditis in Coronavirus Disease 2019 and Immunization Consortium (CERAMICi) created a Research Electronic Data Capture (REDCap) survey to evaluate clinical practice patterns for diagnosis of myocarditis in pediatrics. This survey was distributed to the Society for Cardiovascular Magnetic Resonance community.
Fifty-nine responses from 51 centers were received, with only one response from each center being utilized. Only 35% (18/51) of centers (37% (14/38) North America, 31% (4/13) international) reported using CMR routinely in all patients with a suspicion of myocarditis. Diagnostic uncertainty was noted as the most important reason for CMR, while cost was noted as the least important consideration. The majority of centers reported using the revised LLC (37/51, 72%) compared to original LLC (7/51, 14%) or a hybrid criteria (6/51, 12%). When looking at the use of parametric mapping, only 5/47 (11%) for T1 mapping and 11/49 (22%) for T2 mapping reported having scanner-specific pediatric normative data.
Routine CMR imaging for diagnosis of myocarditis in pediatrics is infrequently performed at surveyed centers despite the focus on a group of non-invasive cardiac imagers. While the majority reported using parametric mapping, few centers reported having pediatric scanner-specific normative data. This highlights an important gap in the utilization of CMR that may aid in the diagnosis of myocardial disease.
心血管磁共振成像(CMR)用于根据原始的路易斯湖标准(LLC)以及最近修订的LLC诊断成人和儿童的心肌炎。修订后的LLC的主要变化包括纳入了参数成像,这显著提高了诊断的敏感性和特异性。随后,科学声明推荐在儿童心肌炎诊断中使用参数成像。然而,参数成像存在一些儿科人群特有的挑战。我们的目标是描述儿科中心用于诊断心肌炎的临床CMR和参数成像实践模式。
2019年冠状病毒病和免疫联盟运动员心肌炎回归的心血管磁共振评估(CERAMICi)创建了一个研究电子数据采集(REDCap)调查,以评估儿科心肌炎诊断的临床实践模式。该调查分发给了心血管磁共振学会社区。
收到了来自51个中心的59份回复,每个中心仅使用一份回复。只有35%(18/51)的中心(北美为37%(14/38),国际为31%(4/13))报告在所有疑似心肌炎患者中常规使用CMR。诊断不确定性被认为是进行CMR的最重要原因,而成本被认为是最不重要的考虑因素。与原始LLC(7/51,14%)或混合标准(6/51,12%)相比,大多数中心报告使用修订后的LLC(37/51,72%)。在查看参数成像的使用情况时,只有5/47(11%)的中心有T1映射的特定扫描仪儿科标准数据,11/49(22%)的中心有T2映射的特定扫描仪儿科标准数据。
尽管调查的中心专注于一组非侵入性心脏成像设备,但儿科心肌炎诊断的常规CMR成像很少进行。虽然大多数中心报告使用参数成像,但很少有中心报告有特定于儿科扫描仪的标准数据。这突出了CMR利用方面的一个重要差距,这可能有助于心肌疾病的诊断。